Equity Research, Broker Reports, and media content on Vivoryon Therapeutics N.V.

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Vivoryon Therapeutics N.V.
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Vivoryon Therapeutics N.V.

Company Profile

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Vivoryon Therapeutics N.V.. We currently have 12 research reports from 2 professional analysts.

Date Source Announcement
09Jul19 12:51 EQS Vivoryon Therapeutics (PBD-NA): Agreement with MOR in I-O, earlier than expected
15Jun19 13:34 EQS Vivoryon Therapeutics (PBD-NA): Fresh funding for AD. Immuno-oncology optionality explored
20Mar19 12:33 EQS Probiodrug (PBD-NA): $15m cash injection from NIH for US Phase IIb in early Alzheimer's
01Nov18 09:42 EQS Edison Investment Research Limited: Edison issues outlook on Probiodrug (PBD)
15Oct18 12:47 EQS Probiodrug AG: Loss announcement a non-event
03Sep18 10:24 EQS Probiodrug (PBD-NA): Phase IIb trial prep for PQ912 in AD continues:
13Jul18 10:27 EQS Probiodrug (PBD-NA): Positive read-across from BAN2401 Phase II data
  • Frequency of research reports

     

  • Research reports on

    Vivoryon Therapeutics N.V.

  • Providers covering

    Vivoryon Therapeutics N.V.